This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Identification
- Generic Name
- Sodium phosphate tribasic dodecahydrate
- DrugBank Accession Number
- DB14622
- Background
Not Available
- Type
- Small Molecule
- Groups
- Experimental
- Structure
Structure for Sodium phosphate tribasic dodecahydrate (DB14622)
- Weight
- Average: 380.119
Monoisotopic: 380.04950453 - Chemical Formula
- H24Na3O16P
- Synonyms
- Phosphoric acid, trisodium salt, dodeahydrate
- Phosphoric acid, trisodium salt, dodecahydrate
- Sodium phosphate dodecahydrate
- Sodium phosphate, tribasic, dodecahydrate
- Trisodium phosphate
- Trisodium phosphate dodecahydrate
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Products
Drug product information from 10+ global regionsOur datasets provide approved product information including:dosage, form, labeller, route of administration, and marketing period.Access drug product information from over 10 global regions.- Active Moieties
Name Kind UNII CAS InChI Key Phosphate ion ionic NK08V8K8HR 14265-44-2 NBIIXXVUZAFLBC-UHFFFAOYSA-K - Over the Counter Products
Name Dosage Strength Route Labeller Marketing Start Marketing End Region Image Fresh Aqua Liquid 1.425 g/475mL Topical Kotuku Inc. 2018-08-13 Not applicable US 
Fresh Aqua Liquid 1.425 g/475mL Topical WALIS, INC. 2019-01-21 Not applicable US Vege Aqua Liquid 1.425 g/475mL Topical Kotuku Inc. 2018-08-13 Not applicable US Vege Aqua Liquid 1.425 g/475mL Topical WALIS, INC. 2019-01-21 Not applicable US - Unapproved/Other Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image Fresh Aqua Sodium phosphate tribasic dodecahydrate (1.425 g/475mL) Liquid Topical Kotuku Inc. 2018-08-13 Not applicable US Fresh Aqua Sodium phosphate tribasic dodecahydrate (1.425 g/475mL) Liquid Topical WALIS, INC. 2019-01-21 Not applicable US Vege Aqua Sodium phosphate tribasic dodecahydrate (1.425 g/475mL) Liquid Topical Kotuku Inc. 2018-08-13 Not applicable US Vege Aqua Sodium phosphate tribasic dodecahydrate (1.425 g/475mL) Liquid Topical WALIS, INC. 2019-01-21 Not applicable US
Categories
- Drug Categories
- Classification
- Not classified
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- B70850QPHR
- CAS number
- 10101-89-0
- InChI Key
- ASTWEMOBIXQPPV-UHFFFAOYSA-K
- InChI
- InChI=1S/3Na.H3O4P.12H2O/c;;;1-5(2,3)4;;;;;;;;;;;;/h;;;(H3,1,2,3,4);12*1H2/q3*+1;;;;;;;;;;;;;/p-3
- IUPAC Name
- trisodium dodecahydrate phosphate
- SMILES
- O.O.O.O.O.O.O.O.O.O.O.O.[Na+].[Na+].[Na+].[O-]P([O-])([O-])=O
References
Clinical Trials
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
Form Route Strength Liquid Topical 1.425 g/475mL - Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
- Predicted Properties
Property Value Source logP -1 Chemaxon pKa (Strongest Acidic) 1.8 Chemaxon Physiological Charge -2 Chemaxon Hydrogen Acceptor Count 4 Chemaxon Hydrogen Donor Count 0 Chemaxon Polar Surface Area 86.25 Å2 Chemaxon Rotatable Bond Count 0 Chemaxon Refractivity 11.29 m3·mol-1 Chemaxon Polarizability 4.93 Å3 Chemaxon Number of Rings 0 Chemaxon Bioavailability 1 Chemaxon Rule of Five Yes Chemaxon Ghose Filter No Chemaxon Veber's Rule No Chemaxon MDDR-like Rule No Chemaxon - Predicted ADMET Features
- Not Available
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
- Not Available
- Chromatographic Properties
Collision Cross Sections (CCS)
Not Available
Drug created at August 28, 2018 16:03 / Updated at June 12, 2020 16:53